Alimera Sciences buy melinda
Start price
01.07.18
/
50%
€13.40
Target price
24.07.18
€37.21
Performance (%)
13.13%
End price
24.07.18
€15.15
Summary
This prediction ended on 24.07.18 with a price of €15.15. The prediction had a final performance of 13.13%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alimera Sciences | - | - | - | - |
| iShares Core DAX® | -0.448% | 2.344% | 15.948% | 18.098% |
| iShares Nasdaq 100 | 0.834% | 5.019% | 30.983% | 56.534% |
| iShares Nikkei 225® | -0.479% | 0.550% | 9.206% | 5.013% |
| iShares S&P 500 | -0.352% | 2.631% | 26.224% | 46.697% |
Comments by melinda for this prediction
In the thread Alimera Sciences diskutieren
Soins de santé | Fabricants de médicaments - Major | Etats-Unis
La société pharmaceutique Nano-Cap Alimera Sciences Inc (NASDAQ: ALIM ) pourrait être triplée en valeur pour trois raisons principales, selon B. Riley FBR.
L'ANALYSTE
L'analyste Andrew D'Silva est une initié la couverture d' Alimera Sciences et une note d' intérêt et d'objectif de 2,75 $.
Stopped prediction by melinda for Alimera Sciences
Alimera Sciences
Start price
Target price
Perf. (%)
€12.76
26.05.19
26.05.19
€13.53
21.09.19
21.09.19
-42.95%
21.09.19
21.09.19
Alimera Sciences
Start price
Target price
Perf. (%)
€18.31
19.10.17
19.10.17
€19.21
19.04.18
19.04.18
-15.75%
19.04.18
19.04.18
Alimera Sciences
Start price
Target price
Perf. (%)
€56.49
15.06.13
15.06.13
€79.50
16.12.13
16.12.13
-56.72%
16.12.13
16.12.13